outbreak of Ebola in West Africa is over 1000.
The world health agency said in a news release on Monday that 1,013
people have died in the outbreak, which has hit Guinea, Liberia,
Sierra Leone and Nigeria.
Authorities have recorded 1,848 suspected, probable or confirmed cases
of the disease, which causes a high fever, vomiting and bleeding. The
outbreak was first identified in March in Guinea, but it likely
started months earlier.
The updated WHO tally includes figures from August 7- 9, during which
52 people died and 69 more were infected.
Ebola is highly lethal and there is no licensed vaccine or treatment
for the disease, but so far three infected people have received an
experimental drug.
The news comes as a US company which makes an experimental drug for
treating the virus sends all its available supplies to West Africa.
"In responding to the request received this weekend from a West
African nation, the available supply of ZMapp is exhausted," said a
statement on the Mapp Bio website on Monday.
"Any decision to use ZMapp must be made by the patients' medical
team," it said, adding that the drug was "provided at no cost in all
cases." The biomedical collaboration between US and Canadian
researchers involves a drug that is manufactured in tobacco leaves and
is hard to produce on a large scale.
The company did not reveal which nation received the doses, or how
many were sent, though CNN reported that Liberia was to receive the
sample doses.
The two American missionary workers who fell ill with Ebola while
working in Monrovia last month were given doses of the drug. Both have
been transported to an isolation unit at Emory University Hospital in
Atlanta, Georgia, where they are receiving continuous care.
A Spanish priest who was infected with Ebola has also been given a
dose, but he died anyway, with virologists saying he probably got the
drug a little too late.
The ethics of distributing experimental medications to some people but
not others was the focus of a special meeting of the World Health
Organisation on Monday.
The US Centers for Disease Control and Prevention have repeatedly
stressed that the drug's effects are unknown, since it has not been
through a process of rigorous clinical trials.
In a statement released by the WHO on Tuesday, the UN agency
stipulated that patients should give consent where possible to being
treated with the drugs and all aspects of their care be transparent.
No comments:
Post a Comment